Correlation Between Cogent Biosciences and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cogent Biosciences and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Biosciences and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Biosciences and Structure Therapeutics American, you can compare the effects of market volatilities on Cogent Biosciences and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Biosciences with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Biosciences and Structure Therapeutics.
Diversification Opportunities for Cogent Biosciences and Structure Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cogent and Structure is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Cogent Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Biosciences are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Cogent Biosciences i.e., Cogent Biosciences and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Cogent Biosciences and Structure Therapeutics
Given the investment horizon of 90 days Cogent Biosciences is expected to generate 1.07 times more return on investment than Structure Therapeutics. However, Cogent Biosciences is 1.07 times more volatile than Structure Therapeutics American. It trades about -0.17 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.21 per unit of risk. If you would invest 1,149 in Cogent Biosciences on September 1, 2024 and sell it today you would lose (198.00) from holding Cogent Biosciences or give up 17.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cogent Biosciences vs. Structure Therapeutics America
Performance |
Timeline |
Cogent Biosciences |
Structure Therapeutics |
Cogent Biosciences and Structure Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cogent Biosciences and Structure Therapeutics
The main advantage of trading using opposite Cogent Biosciences and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Biosciences position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.Cogent Biosciences vs. Larimar Therapeutics | Cogent Biosciences vs. Kura Oncology | Cogent Biosciences vs. Kiniksa Pharmaceuticals | Cogent Biosciences vs. Ideaya Biosciences |
Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |